Non-gadolinium-enhanced 3-dimensional magnetic resonance angiography for the evaluation of thoracic aortic disease: a preliminary experience
- PMID: 20200628
- PMCID: PMC2829812
Non-gadolinium-enhanced 3-dimensional magnetic resonance angiography for the evaluation of thoracic aortic disease: a preliminary experience
Abstract
We compared image quality and diagnostic accuracy of a noncontrast 3-dimensional magnetic resonance angiography (NC-MRA) technique (balanced steady-state free-precession sequence) to contrast-enhanced MRA (CE-MRA) for evaluation of thoracic aortic disease.The CE-MRA provides 3-dimensional high-resolution images of the thoracic aorta that are important in the evaluation of patients with aortic disease. However, recent concerns with the potential nephrotoxic effects of gadolinium contrast medium limit the application of CE-MRA for patients who have significant renal insufficiency.Twenty-one patients (mean age, 51 yr; 18 men) who underwent NC-MRA and CE-MRA for evaluation of thoracic aortic disease were retrospectively identified. Data sets were reviewed by 2 readers who were blinded to the patients' information. The thoracic aorta was divided into 5 segments. Image quality and reader confidence for diagnosis of aortic pathology were rated on 5-point scales. The Wilcoxon matched-pairs signed rank test and the Student t test were used for comparisons.The NC-MRA identified all pathologic findings with 100% diagnostic accuracy and similar reader confidence, when compared with CE-MRA. Although overall image quality was not significantly different, superior image quality was observed at the aortic root (4.4 +/- 0.8 vs 3.2 +/- 0.9, P <0.0005) and ascending aorta (4.1 +/- 1 vs 3.7 +/- 0.9, P=0.05) respectively.In conclusion, NC-MRA is a useful alternative for evaluation and follow-up of thoracic aortic disease, especially for patients with poor intravenous access or contraindications to gadolinium use.
Keywords: Aneurysm, dissecting/diagnosis; aorta, thoracic/pathology; aortic aneurysm, thoracic/diagnosis; aortic diseases/diagnosis/radiography; artifacts; contrast media/toxici-ty; gadolinium/diagnostic use/toxicity; magnetic resonance angiography; retrospective studies.
Figures







Similar articles
-
Highly accelerated single breath-hold noncontrast thoracic MRA: evaluation in a clinical population.Invest Radiol. 2013 Mar;48(3):145-51. doi: 10.1097/RLI.0b013e31827994c2. Invest Radiol. 2013. PMID: 23249647
-
Noncontrast 3D steady-state free-precession magnetic resonance angiography of the whole chest using nonselective radiofrequency excitation over a large field of view: comparison with single-phase 3D contrast-enhanced magnetic resonance angiography.Invest Radiol. 2008 Jun;43(6):411-20. doi: 10.1097/RLI.0b013e3181690179. Invest Radiol. 2008. PMID: 18496046
-
Comparison of native high-resolution 3D and contrast-enhanced MR angiography for assessing the thoracic aorta.Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):651-8. doi: 10.1093/ehjci/jet263. Epub 2014 Jan 7. Eur Heart J Cardiovasc Imaging. 2014. PMID: 24399340
-
[Diagnosis of renal artery stenosis with magnetic resonance angiography and stenosis quantification].J Mal Vasc. 2000 Dec;25(5):312-320. J Mal Vasc. 2000. PMID: 11148391 Review. French.
-
[Contrast-enhanced magnetic resonance angiography].Ned Tijdschr Geneeskd. 1999 May 22;143(21):1087-93. Ned Tijdschr Geneeskd. 1999. PMID: 10368744 Review. Dutch.
Cited by
-
Multimodality imaging assessment of bicuspid aortic valve disease, thoracic aortic ectasia, and thoracic aortic aneurysmal disease.Cardiovasc Diagn Ther. 2021 Jun;11(3):896-910. doi: 10.21037/cdt-20-279. Cardiovasc Diagn Ther. 2021. PMID: 34295712 Free PMC article. Review.
-
Cardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population.World J Clin Pediatr. 2016 Feb 8;5(1):1-15. doi: 10.5409/wjcp.v5.i1.1. eCollection 2016 Feb 8. World J Clin Pediatr. 2016. PMID: 26862497 Free PMC article. Review.
-
Correcting versus resolving respiratory motion in free-breathing whole-heart MRA: a comparison in patients with thoracic aortic disease.Eur Radiol Exp. 2019 Jul 31;3(1):29. doi: 10.1186/s41747-019-0107-4. Eur Radiol Exp. 2019. PMID: 31363865 Free PMC article.
-
Aortic regurgitation: A multimodality approach.J Clin Ultrasound. 2022 Oct;50(8):1041-1050. doi: 10.1002/jcu.23299. J Clin Ultrasound. 2022. PMID: 36218214 Free PMC article. Review.
-
Single-Shot Coronary Quiescent-Interval Slice-Selective Magnetic Resonance Angiography Using Compressed Sensing: A Feasibility Study in Patients With Congenital Heart Disease.J Comput Assist Tomogr. 2018 Sep-Oct;42(5):739-746. doi: 10.1097/RCT.0000000000000760. J Comput Assist Tomogr. 2018. PMID: 29958198 Free PMC article.
References
-
- Krinsky GA, Rofsky NM, DeCorato DR, Weinreb JC, Earls JP, Flyer MA, et al. Thoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging. Radiology 1997;202(1):183–93. - PubMed
-
- Neimatallah MA, Ho VB, Dong Q, Williams D, Patel S, Song JH, Prince MR. Gadolinium-enhanced 3D magnetic resonance angiography of the thoracic vessels. J Magn Reson Imaging 1999;10(5):758–70. - PubMed
-
- Loewe C, Schillinger M, Haumer M, Loewe-Grgurin M, Lammer J, Thurnher S, et al. MRA versus DSA in the assessment of occlusive disease in the aortic arch vessels: accuracy in detecting the severity, number, and length of stenoses. J Endovasc Ther 2004;11(2):152–60. - PubMed
-
- Othersen JB, Maize JC, Woolson RF, Budisavljevic MN. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure. Nephrol Dial Transplant 2007;22 (11):3179–85. - PubMed
-
- Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007;188(2):586–92. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources